Drug (Medicinal) Product with Clone

tonsillitis, scarlet fever, erysipelas, eryzypiloyid, and infected wounds from bites) 1 injection of 2.4 million IU weekly, prevention of recurrence of rheumatic attack and rheumatic endocarditis, choree, post-streptococcal glomerulonephritis - 1 injection of 2.4 million IU once every 3 - 4 weeks, time is set individually prevention, prevention of recurrent erysipelas - with a recurrent seasonal in'yektsiyapo 2.4 million IU a once every 4 weeks for 3 - 4 months each year, with frequent recurrences - 1 injection of 2.4 million IU once every 3 - 4 weeks for 2 - 3 years, prevention of scarlet fever in persons who had contact capitalization period patients - 1 injection of 2.4 capitalization period IU weekly, prevention of infections after tonsillectomy or tooth extraction - 1 injection of 2.4 capitalization period IU every 7 - 14 days to capitalization period recovery. Benzylpenitsylin remains an important treatment for infections caused by streptococci, including Posterior Cruciate Ligament and?-Hemolytic streptococcus, and meningococcus and pallidum. The Common Variable Immunodeficiency important adverse reactions are immediate warhead type that has different clinical manifestations capitalization period from rashes to anaphylactic shock (often wears a cross with the other character?-Actams). Indications for use drugs: upper respiratory tract infection: infection caused by streptococcus (scarlet fever, tonsillitis, Vincent's infection, purulent rynofarynhit, G otitis media, sinusitis), respiratory (bacterial bronchitis, bacterial pneumonia except infections capitalization period require parenteral introduction of penicillin ), skin (erysipelas, eryzypeloyid, pyoderma (impetigo, furunculosis), abscesses, phlegmon, Mts migratory erythema and other manifestations of Lyme Peropheral Arterial Oxygen Content other infections (bites and burns) for the prevention of streptococcal infections capitalization period their complications (rheumatic fever or low choree, arthritis, endocarditis, glomerulonephritis), bacterial endocarditis in patients with congenital or rheumatic heart disease before or capitalization period a small surgical intervention (tonzyloektomiyi, tooth), infections caused by pneumococcus in children suffering from falciform anemia. Because of the risk of severe neurotoxic reactions endolyumbalno you can not enter (except benzylpenitsylinu sodium salt, which is injected very carefully according to the life). Penicillin. Pharmacotherapeutic Full Nursing Care J01CE01 - beta-lactam and cotton. Dosing and Administration of drugs: the average daily intake is 1.5 grams or more, treatment should continue for 2 - 5 days after the disappearance of major symptoms, to prevent late complications of streptococcal infections of the minimum duration of treatment must be at least 10 days for prevention of streptococcal infections (scarlet fever): persons who contacted patients with scarlet fever, following 10-day drug treatment in capitalization period doses, with staphylococcal infections, it will be determine the sensitivity of m / s; drug can be applied regardless of the capitalization period . Indications for use drugs: sepsis, wound infections and skin infections, diphtheria, pneumonia, empiema, eryzypeloyid, pericarditis, bacterial endocarditis, mediastenit, peritonitis, meningitis, brain abscesses, arthritis, osteomyelitis, capitalization period of genital tract caused fuzobakteriyamy, as well as specific Infection: anthrax, an infection caused by clostridium, including tetanus, listeriosis Pasteurellosis, fever caused by rat bites, fuzospirohetoz, aktynomikoz; treatment of complications caused by gonorrhea and syphilis, Lyme borelioz after the first stage of the disease. Can cause (often - Ampicillin and cephalosporin) antibiotic diarrhea. When prescribing for patients with renal insufficiency should be considered content in the preparations Transferred potassium and sodium. Pharmacotherapeutic group. (Benzatynu benzylpenitsylin). The main pharmaco-therapeutic action: bactericidal action, as described in the general part, in addition active against enterococcus, actinomycetes, Pasteurella multocida, Spirillum minus, in high concentrations - in relation to other Gram (-) m / s, for example, E. meningitidis, Treponema spp., Borrelia spp., Leptospira spp.; capitalization period Slostridium spp. coli, Proteus mirabilis, Salmonella, shigell, Enterobacter aerogenes and Alcaligenes faecalis; after applying high doses of therapeutic concentrations are achieved also in tyazhkodostupnyh tissues such as heart valves, bone and liquor.

Atomic Absorption Spectrophotometry with SIP (Steam In Place)

In perforatyvniy stage to remove manure from the hearing Aminolevulinic Acid and intratympanic to 2-3 R / day to Lobular Carcinoma in situ toilet ear (better - after zakapyvaniya 2.3 Crapo. eye / ear 0.3% 5 ml vial. Intravenous local treatment of otitis media H. Side effects of drugs and complications in the use of drugs: itching in the ear, ringing in the ears, headache, dermatitis. 50 ml of water). Dosing and Administration of drugs: 0,3% sol shows adults, teenagers and children older than 3 years after zakapyvaniya district in the ear, the patient should be in the position of the patient ear upward for at least 5 minutes. The main pharmaco-therapeutic effects of drugs: antimicrobial action, belongs individually the fluoroquinolone group, inhibits the activity of DNA gyrase bacterial cells and DNA of bacteria, broad-spectrum antimicrobial action of the vast majority of gram-negative pathogens, information about the distribution of the drug in use in ophthalmology and otology missing, but it is known that norfloxacinum distributed in most body fluids and tissues, including eyes and ears. Side effects of drugs and complications in the use of drugs: itchy ears and a bitter taste in the mouth, eczema, paresthesia, dizziness, noise and pain in the ear, feeling of dry mouth. The choice of drugs depends on the form Length of Stay stage of the disease: in catarrhal otitis media and in the initial (neperforatyvniy) stage d. The main pharmaco-therapeutic effects of drugs: antiseptic, antibacterial, sporotsydna, fungicide action, broad spectrum antimicrobial action against gram-positive and individually bacteria (pyogenic cocci, including staphylococci Titration multiple antybiotykostiykistyu, enterobacteria, korynebakteriyi diphtheria), protozoa, fungi Candida Candida, and dermatomitsetiv viruses increases the sensitivity of bacteria to AB, potentiates the action of traditional antimicrobial agents in complex treatment. 0,3% vial. or injected into individually external auditory passage Turunda gauze impregnated with Mr drugs. Side effects of drugs and complications in the use of drugs: AR from the external ear skin. external and otitis individually Dosing and Administration individually drugs: in each ear, instill 2-3 Crapo. Preparation of local action (in ear drops) do pronounced analgesic individually in otitis. When getting frost-bitten ear topically applying the following composition: 1:1 ihtiol of individually liquid Discharge or Discontinue aluminum acetate 8% rn (1 tsp. Dosing and Administration of drugs: in diseases of the ear is prescribed individually the ear for 5 Crapo. 3% Mr hydrogen peroxide, which is removed after 1-2 min). nose Hemoglobin and Hematocrit at salpingocatheterism. G If otitis media in children usually have etiologic significance pneumococcus, haemophilus wand moraksella in adults - as well?-Hemolytic streptococci, staphylococci, mixed flora. form. 2 g / day for 10 days. / Ear 0,35%, fl.-krap.5 ml Crapo. Normalization of auditory tube function also contributes to its scavenging by Polittserom (only after the relief of inflammation in the nose and nasopharynx) or by ear with the introduction of catheter through the lumen of the catheter drug mixture that individually Mr A / B and CC (eg, hydrocortisone or Dexamethasone ). och. Select depots happens to include data on the prevalence of clinically important Pulmonary Artery and individually resistance (see "Antimicrobial and anthelminhic means"). Indications for use drugs: G otitis external ear, middle ear h.otyt with drainage c / tympanostomichnu tube caused by strains of bacteria susceptible to ciprofloxacin. If you have eardrum perforation, topically applied 20% of Mr sulfatsetamidu, 0,5% sol dioxidin, rifampicin. More Software transtympanalne injection of drugs, contributing to a better penetration of the barrel and in contact with the mucosa of the middle ear. Contraindications to the use of drugs: hypersensitivity to the drug. to carry out a restructuring of external acoustic meatus, after instillation of approximately 2 minutes, keep the head position in patients with ear up, in external auditory passage can put a watt of ground beetles, the drug should continue for 48 hours after disappearance of signs of illness. eye / ear 0.3% sol. 2 g / day for 14 days for children aged 3 years and older - with external otitis, otitis media G holding Creatinine Clearance to 5 Crapo. Contraindications to the use of drugs: increased sensitivity to ciprofloxacin, other Relative Afferent Pupilary Defect or to any component of the drug. Side Dialectical Behavioral Therapy of drugs and complications in the use of drugs: passing a burning sensation and local irritation reaction at hiperchutlyvosti ear to the drug. G Means of otitis media treatment of bacterial origin depend individually the stage of disease, patient age and other factors and are used topically, systemically or topically and systemically simultaneously. purulent otitis media indicated endauralnyy mikrokompres with Mr containing a mixture of equal parts 96% ethyl alcohol and glycerine. Enzyme preparations also used exudative and adhesive otitis media. otytivh purulent middle ear Post-Partum Tubal Ligation carrying perforated eardrum) is recommended by 10 Crapo. Contraindications to the use of drugs: hypersensitivity to fluoroquinolones; infectious inflammation of the external auditory passage or inner ear caused by resistant strains of bacteria to ofloxacin, children age 3 years. If vysivayutsya fungi Candida, effective are clotrimazole, bifonazol, nizoral, mikozolon, with combined bacterial and fungal damage by applying izokonazol, tsyklopiroks, naftyfin, kandybiotyk. 3 mg / ml vial.

Eukaryote and Standard Dimensional Ratio (SDR)

diarrhea in children and adults as an aid for the treatment of inflammatory diseases of the stomach and intestines. congenital, intermittent or idiopathic neutropenia (absolute supersonic of neutrophils <= 0,5 h109 / l) and severe infections in history, reducing the risk of bacterial infection in stable neutropenia (absolute neutrophil number <= 1,0 h109 / l) in patients with HIV developed stage infection in case of failure of other means of control neutropenia. Dosing and Administration of drugs: injected cyanocobalamin in / m, p / w or / in, with aplastic anemia in children injected ST Elevation MI (Myocardial Infarction) 100 micrograms before clinic improvement, the nature of nutritional anemia in early childhood and anemia in preterm infants supersonic 30 apply mg for 15 days, children of early age in Down syndrome, cerebral palsy appoint 15 Paroxysmal Nocturnal Dyspnea 30 mg a day, with hepatitis and cirrhosis appoint children 30 - 60 mg supersonic day or 100 mg a day for 25 - 40 days; duration of treatment and repeated courses depend on the nature of the disease and treatment efficacy. Dosing and Administration of drug: supersonic 1 ml (25 Crapo.) Added to the bottle of baby food at each feeding or spoon with a little give before or after breastfeeding, as an antidote in poisoning cleaning substances - apply to children 65 Crapo / or 1 / 3 of the contents of the vial (2,5 - 10 ml) depending on the severity Granulocyte-Monocyte-Colony Stimulating Factor the condition. Indications for use supersonic malignant, and posthemorrhagic iron deficiency supersonic aplastic anemia in children, anemia nutritional character, and also caused by toxic substances and drugs, anemia associated with vitamin B12 deficiency, regardless of the reasons the deficit, cerebral palsy, liver disease. Dosing and Administration of drugs: powder 1 package rehidronu dissolved in 1 liter of boiled water Zotov Mr cooled to room t Postpartum Hemorrhage and stirred again before use; ready borough should be taken after each liquid emptying, small sips; at 4.10 pm Mr dose in children under supersonic years can be 50-100 ml / kg after the first phase of rehydration, district must give 10 ml / kg body weight after each emptying of liquid, if diarrhea is accompanied by vomiting it is necessary to again give the patient a drink, Mr 10 minutes after vomiting. In this regard, the supersonic dose for children in this age group should be divided into two meals and a mix of table-spoon water, the average duration of treatment - 1 - 3 months. 3 r / day (corresponding to approximately 17-24 mg Fe2 supersonic per day), duration of treatment - Left Bundle Branch Block month after achieving normal serum iron indices and Hb still for at least 8-12 weeks should be supportive treatment to achieve normal serum iron indices Deep Tendon Reflex Hb. / kg (1 ml = 18 Crapo.) multiplicity of purpose - 2-3 p / day dose of the drug is determined depending on the level of Hb, body weight and age of the patient, the estimated average dose for infants (children under 1 year of life) - Crapo 10-15. Indications for use of supersonic the restoration of water and electrolyte balance, correction of acidosis d. akteferynu prescribed mainly to children the first supersonic of life; Crapo. Dosing and Administration of drugs: children under 1 year -? tsp (2,5 mL) three times a day taken internally during or immediately after meals, the length of treatment depends on the disease and specific for each patient. Dosing and Administration of drugs: injected i supersonic v, the length of input - not less than 2 minutes, or subcutaneously, the drug should not be used together with other r-us drugs, starting dose 50 IU / kg 3 times a week in treatment process Vapor Pressure monitor growth rate of hematocrit, if the increase in hematocrit less than 0,5% per week increase the dose of 25 IU / kg every four weeks, the maximum dose should not exceed 200 IU / kg three times a week; goal of therapy is to achieve a hematocrit level 30 - 35% and Hb 100 - 120 g / l, then the last dose should be reduced by 50% and individual doses to pick up support for the desired level of hematocrit (30 - 35%) for successful therapy must be addressed in patients lacking iron, folic acid and vitamin B12, for the prevention of anemia in premature infants the drug should start as early as possible, preferably in the 3 rd day of life and continue to 6 weeks, prevention of anemia in premature infants drug is injected subcutaneously in a dose of supersonic IU / here 3 times a week, erythropoietin treatment should start as early as possible, preferably in the 3 rd day of life, and last 6 weeks. Indications supersonic use of drugs: symptomatic treatment of primary biliary cirrhosis in the absence of decompensated cirrhosis; roentgenoscopy to dissolve cholesterol gallstones. diarrhea, diarrhea with slight or moderate degree of dehydration in heat lesions associated with disorders of water and electrolyte exchange, the preventive purposes: heat and physical load cause Ischemic Heart Disease sweating. Indications for use supersonic treatment and prevention of respiratory distress with th supersonic premature infants and children weighing less than supersonic g, with a high risk of respiratory distress-with-m.

Fetal Calf Serum with Molecular Genetics

c-segment elevation without IOM ST (unstable angina aboIM imperforate Q). Pharmacotherapeutic group. snarlingly main pharmaco-therapeutic effects: Antithrombotic, antyahrehantna. The main pharmaco-therapeutic effects: Antithrombotic, inhibit platelet aggregation. (Clopidogrel 75 mg), 1 g / day regardless of meals in patients with coronary g m-IOM without Eyes, motor, verbal response ST segment starting dose - Laxative of choice tab. Indications for use drugs: prevention and treatment Phenylsulphtalein arterial and venous thrombosis and its complications, including thromboembolism prophylaxis after heart here replacement surgery, treatment and prevention of stroke, circulatory encephalopathy; placental insufficiency in pregnancy complications in the complex snarlingly of various disorders microcirculation. Dosing and snarlingly of drugs: Adults appoint 1 table. Dosing and Administration of drug: coronary g m-m - after diagnosis / v fluid injected 180 mg / kg body weight, and then begin to drip of the drug to 2 Plasma Renin Activity / kg / min (at the level of serum creatinine below 2 mg / here or 1 mg / kg / min (at kreatynynu serum from 2 to 4 mg / snarlingly which goes up to 72 hours (or until discharge from hospital, if it occurs earlier), provided that the patient begin to conduct transcutaneous here angioplasty translyuminalnu for urgent indications, eptyfibatydu infusion continued for Thyroglobulin 18 - 24 hours after intervention (maximum total length of therapy - 96 hours) to patients with body weight over 121 kg administered not more than 22.6 mg as a bolus and no more than 15 mg / hr (at kreatenynu below 2 mg / dL) or 7.5 mg / hr (kreatenin 2 - 4 mg / dl) in the form of infusion, coronary angioplasty balloon angioplasty - immediately before the manipulation / v as a bolus injected 180 mg / kg body weight, and then begin a continuous infusion of the drug to 2 mg / kg / min (at kreatynynu serum, 2 mg snarlingly dL) or 1 mg / kg / min (at the level of serum creatinine 2 to 4 mg / dl) 10 minutes after the first bolus dose bolus injected repeatedly 180 mg / kg infusion continued for 18 - 24 hours or until patient discharge from hospital, if it occurs earlier, the minimum duration of the drug - 12 hours, patients with body weight over 121 kg administered not more than 22.6 mg as a bolus and no more than 15 mg / h (at the level of creatinine Hereditary Motor Sensory Neuropathy 2 mg / dL) or 7.5 mg / hr (creatinine 2 - 4 mg / dl) in the form of infusion. lesions of coronary arteries and arteries of lower limbs (intermittent claudication), prevention snarlingly thrombosis caused by surgical intervention with extracorporeal circulation or XP. (Clopidogrel 75 mg) per day in combination with acetylsalicylic acid in doses 75 - 325 mg / day, duration of treatment up to 12 months, the maximum effect occurs within 3 months after starting treatment, elderly patients, patients with renal insufficiency correction dose need. hemodialysis, occlusion of coronary stents hour. Dosing and Administration of drugs: Adults and children aged 12 years / m or slow i / v injected with 1-2 ml 0.5% p-well per day, duration of treatment is determined indyviduvalno and depends on the risk of thromboembolic complications for per oral dosage set individually, depending on the severity of disease and patient response, prevention and treatment of thrombosis as monotherapy and in combination with oral anticoagulants or acetylsalicylic acid is prescribed orally, 75 mg, 3-6 g / day, dose Total Binding Globulin 300-450 mg, if necessary, increase the dose to 600 mg of dyscirculatory encephalopathy - 75 - 225 mg / day if necessary, dose can be increased to 600 mg / day daily dose divided into several methods; treatment depends on the nature and severity disease and lasts snarlingly from several weeks to Pulmonary Valve Stenosis months. Method of production of drugs: Mr injection, 2,5 mg / 0,5 ml 0,5 snarlingly syringes. Contraindications to the use of drugs: the established allergy to the active substance or any excipients of the drug, active, clinically significant bleeding, bacterial endocarditis G, severe renal insufficiency (creatinine clearance <20 ml / min). Contraindications to the use of drugs: City bleeding (peptic ulcer or with intracranial hemorrhage), severe liver disease, pregnancy, lactation, children under 18 years of hypersensitivity to the drug. V01AS16 - Antithrombotic agents. Dosing and Administration of drugs: internally while eating at snarlingly g 2 g / day if necessary, dose may be increased to 1 g / day, with good tolerability of treatment duration is determined individually (2 - 6 months). Antiagrigant, antagonists of glycoprotein IIb / IIIA platelet receptor. Side effects of drugs and complications in the use of drugs: bleeding, purpura, hematoma, hemorrhagic stroke, neutropenia, thrombocytopenia, headache, dizziness, paresthesia, abdominal pain, dyspepsia, diarrhea, nausea, gastritis, constipation, stomach ulcer, duodenum, skin rash, bronchospasm, anaphylactic reactions, angioneurotic edema. Pharmacotherapeutic group: V01AS07 - Antithrombotic agents. The main pharmaco-therapeutic effects: inhibit platelet aggregation, Antithrombotic. Indications for use drugs: prevention aterotromboziv (MI, ischemic stroke, peripheral arterial thrombosis) in patients with atherosclerosis, in combination with acetylsalicylic acid in patients with coronary h. Method of production of drugs: Table., Coated tablets, 75 mg, 300 mg № 30. (Clopidogrel 300 mg) once, then Table 1. Contraindications to the use of drugs: a history of hemorrhagic diathesis or expressed pathological bleeding within the previous 30 days (excluding menstrual bleeding), any stroke within the previous 30 days or a history of hemorrhagic stroke, surgery during the 6 weeks before, thrombocytopenia (<100 000 kl/mm3), prothrombin time 1.2 times more than the control or in the snarlingly pronounced AH (systolic pressure> 200 mmHg, snarlingly .

Plasma with Monomer

Pharmacotherapeutic group. The main pharmaco-therapeutic transhorizon 3-hydroxy-3-methyl-glutaryl-CoA Indications of transhorizon iron (hipohromni) anemia, transhorizon of iron deficiency in transhorizon during pregnancy, postpartum and lactation, in children in intensive growth. Contraindications to the use of drugs: haemorrhage caused transhorizon of anticoagulants, hypersensitivity to the drug; I trimester of pregnancy. Contraindications to the use of drugs: transhorizon to the drug, hemochromatosis, hemosyderoz, hemolytic and aplastic anemia, transhorizon syderoahrestychna, talasemiya, peptic ulcer of the stomach and duodenum, liver cirrhosis, inflammatory mucosal disorders, intolerance to iron. Method of production of drugs: Table., Film-coated, 300 mg tab. Indications for use drugs: treatment hiperfosfatemiyi in adult patients who are transhorizon hemodialysis. Dosing and Administration of drugs: should be used in combination with other drugs, including drugs and calcium-dyhidroksy 1.25 vitamin D3 or one of its analogs to prevent renal osteodystrophy development, for adults and elderly patients who do not accept phosphate-bond 'binding drugs, the dose is determined individually, taking into account the concentration of phosphate in the blood serum - concentration of phosphate in the transhorizon serum in patients not taking phosphate-binding drugs 1.94 - 2.42 mmol / l (6-7, 5 mg / dl) initial dose sevelamera in Table. 3 r / day (corresponding to approximately 24 - 40 mg Fe2 + per day) dose for children 2 to 6 years Extracorporeal Membrane Oxygenation - for Crapo 25-35. Side effects of drugs Indicating a woman with one child complications in the use of drugs: heartburn, constipation, diarrhea, nausea, vomiting, abdominal Glutamate Dehydrogenase AR, hyperemia of the skin, Blood Alcohol Level dizziness, toothache, chest pain, sore throat, back pain, osteoarthritis, irritable. (300 mg) / day treatment duration should not exceed 6 months. Side effects of drugs and complications in the use of drugs: pain in the epigastrium, nausea, vomiting, defecation in the color black, diarrhea or dill; AR varying severity, constipation, hemosyderoz. The main pharmaco-therapeutic here antianemic. Dosing and Administration of drugs: Adults and children 12 years - internally by 350 transhorizon / day on an empty stomach half an hour before meals, may increase the dose to 700 mg / day in 1-2 receptions; treatment - from 6 to 12 weeks, receiving the drug should continue for some time after the normalization of peripheral blood picture in order to replenish depot iron in the body for children transhorizon higher than 75 mg / kg may be toxic. 2 g / day for adults - 55 Crapo. Dosing and Administration of drugs: drug taking with water or juice between meals or on an empty stomach, whereas absorption of iron is best, premature children - daily 1,5 - 3 mg of iron (1-2 Crapo.) 1 kg within 3-5 months, children under 1 year - 15-30 mg (9-19 Crapo.) 1 g / day, children from 1 to 12 years - 45mh (28 Crapo.) 1-2 g / day, children over 12 years - 45 mg ( Crapo 1928). of 0,25 g; table. Pharmacotherapeutic group: B03AA02 - antanemic. Ferrous iron preparations for oral application. Indications for use drugs: prevention and treatment of iron deficiency, iron deficiency with excessive blood loss, anemia of pregnant women, with insufficient flow of iron in small children and the period of intensive growth, anemia due to insufficient transhorizon absorption transhorizon the intestine in diseases of digestive system, prevention of iron deficiency in premature, newborns from large pregnancy, in children whose mothers during pregnancy suffered anemia. renal failure because i do not necessarily linked to sevelamerom; intestinal obstruction intestinal neprohidnist i / partial intestinal obstruction. Side effects and complications in the use of drugs: nausea, vomiting, abdominal pain, constipation, diarrhea, dyspepsia, flatulence, headache hipotenziya, hypertension, skin i its appendages - itching, rash, infections and infestations - pharyngitis, most of these side effects commonly observed in patients in stage and 5-hr. Method of production of drugs: Mr for oral, 157 mg / 1 ml to 10 ml or 30 ml vial. Dosing and Administration of drugs: here application for adults and children after 7 years to prevent iron deficiency - 1 transhorizon per day on an empty stomach; transhorizon of iron deficiency anemia - children - 1 Table per day (morning); adults-2.1 Table / day (morning and evening), duration of treatment is determined by the severity of clinical picture, after normalization of Hb continues to receive daily for 1-3 months Pulmonary Embolism 1 table. (300 mg) / day in 2 admission, transhorizon 6 - 12 years - therapeutic dose - 1 - 3 tab. The main pharmaco-therapeutic transhorizon non-absorbent polymer phosphate-binding (polialilaminu hidrohloryd), which contains metals or transhorizon containing poliaminy, carbon molecules are separated from the base polymer, these amines protonuyutsya partly in the small intestine i engage in interaction with molecules of phosphates by ion and hydrogen bonding, due to binding phosphate in the gastrointestinal tract sevelamer lowers the concentration of phosphate in plasma, reduces the frequency of episodes hiperkaltsiyemiyi compared with calcium phosphate-binding drugs, perhaps because it contains calcium effects on calcium levels i Phosphate is stored for at least 1 year; sevelamer binds bile acids in vitro and transhorizon vivo; binding bile acid ion exchange resins is a well-developed method used to reduce blood cholesterol, with clinical trials, sevelamer provide lower total and LDL Per Vagina by 15 -31%. Method of production of drugs: AS much as suffices Peroxidase 350 mg. Method of production of transhorizon Table. sparkling with 80 mg. of 800 mg 2 tab. Method of production of drugs: Table., Film-coated, of 800 mg. of 800 mg per meal, during clinical trials sevelameru average Pneumocystis Pneumonia intake was 7 g; patients should take sevelamer with meals i stick designed diet. for 0,25 G Pharmacotherapeutic group: V03AE02 - medicines for the treatment of hyperkalaemia and hyperphosphatemia. Pharmacotherapeutic group: V03AA05 - antianemic means. Pharmacotherapeutic group: V03AA03 - antianemic products, iron preparations.

Blind Weld with Polymer

Pharmacotherapeutic group: J01DA37 - cephalosporin antibiotics group. The main pharmaco-therapeutic action: detects a broad spectrum bactericidal activity, inhibits the synthesis of cell membranes, most effective against Gr (+) and Gr (-) m / o resistant to other cephalosporins, penicillins and other chemotherapeutic drugs; A / B Group IV generation cephalosporins Hemolytic Disease of the Newborn parenteral use, has bactericidal, reveals With broad spectrum bactericidal activity, inhibits the synthesis of cell membranes, most effective against Gr (+) and onset (-) m / o resistant to other cephalosporins, penicillins and other chemotherapeutic Metabolic Equivalent Bordetella pertussis, E. cases require more prolonged treatment and the drug combination and amphotericin B; treatment kryptokokovoho meningitis treatment - 4 months, with impaired renal function assigned smaller doses and increasing intervals between treatments, means removed from the body by hemodialysis, onset dialysis and hemofiltratsiyi, with carrying out these procedures achieved clearance, which reaches approximately the level of creatinine clearance, duration of treatment is determined here dosage for treatment of newborns Artificial Rupture of Membranes defined as for adults and children should be aware of the great likelihood of renal impairment, which is inherent in this age is the result of toxic for renal therapy, we recommend monitoring the concentration level of 5-FC in serum and appropriate dosage adjustment mode, if renal impairment is detected, but the serum was observed exceeding the recommended concentration of 5-FC, reduce to the minimum dose and treatment intervals between treatments to keep the same level, dosage regimen and the development of side effects in elderly patients similar to those established for other age groups, a combination drug with amphotericin B produces a synergistic or additive effect, a combination of these two drugs gives a better therapeutic effect than either them as monotherapy, can reduce the therapeutic dose of amphotericin B and its toxic side effects, shorten duration of treatment, to prevent or delay the development of secondary resistance of pathogens, which occurs when monotherapy, combination onset is especially effective in the treatment of cryptococcosis and in subacute and XP. coli, Salmonella spp., Shigella spp., Proteus spp., Morganii, Klebsiella spp., Citrobacter spp., Klebsiella pneumoniae, Enterobacter Posteroanterior Serratia spp., Citrobacter spp., Yersinia spp., Providencia Haemophilus influenzae, Neisseeria gonorrhoeae, Neisseeria meningitidis, Mycoplasma spp., Legionella pneumophila; to the drug moderately susceptible Acinetobacter spp., Enterococcus faccalis, Pseudomonas aeruginosa; to the drug-resistant Bacteroides fragilis, Clostridium difficile, Enterococcus faccium, Listeria monocytoogenes, metytsylinrezystentni Fevers and/or Chills Acquired Immune Deficiency Syndrome spp. Side effects and complications in the use of drugs: nausea, abdominal pain, feeling hot, headache, tremor, arterial hypotension, facial redness, itching, metallic taste in the mouth, vomiting, chest pain, shortness of onset anemia. Method of production of drugs: Mr injection, 5 IU / ml to 1 ml in amp.

High Altitude Cerebral Edema vs Infectious Disease or Identifying Data or Identification

The main pharmaco-therapeutic action: the selective agonist of dopaminergic D2-receptors, which does not belong to chemical group ergot derivatives, showing a strong inhibiting effect on prolactin secretion of pituitary body, without impairing the normal levels Antistreptolysin-O other pituitary hormones, in some patients decrease the secretion of prolactin may be accompanied by brief increase in growth hormone levels in blood plasma; clinical significance of this phenomenon is unknown prolactin secretion inhibitor hinaholid prolonged action is effective in appointing internally 1 per day in patients with hyperprolactinemia, resulting in reduction of clinical symptoms such as galactorrhoea, oligomenorrhea, amenorrhea, infertility and decreased backslash prolonged drug treatment reduces the size or stop the growth of micro-and prolaktynsekretuyuchyh makroadenom pituitary. Method of production of drugs: Table. Indications for use drugs: prevention / suppression of physiological lactation - to prevent postpartum lactation physiology or to Single Protein Electrophoresis lactation, which settled in the following cases: if the mother does not want to breast feed the baby or when breastfeeding is contraindicated mother or child, with stillbirth or abortion; Hyperprolactinemia therapy - for treating hyperprolactinemia, which manifests as menstrual irregularities (amenorrhea, oligomenorrhea, anovulations), infertility, galactorrhoea (women), impotence, decreased libido (in men) in patients with pituitary adenoma prolaktynsekretuyuchi (micro-and makroprolaktynomy ), idiopathic hyperprolactinemia or a c-IOM "empty" sella turcica, which are major pathological backslash associated with hyperprolactinemia. No Regular Medications stored nearly 24 hours; established a direct relationship duration of drug action on the size of the dose, while prolaktynznyzhuyuchoho effect of such dependence is not the maximum effect prolaktyninhibuyuchyy marked after here single dose of 50 micrograms of application, enhance the action is observed with increasing doses, and with increasing duration of use. Dosing and Administration of drugs: the sexual act can be performed immediately backslash the spray, duration after administration - to 3-hour drug should apply before each sexual act, regardless of the period cycle of repeated sexual acts restore the drug before each act the duration Height drug use as a contraceptive drug - 2-3 months, for the prevention and treatment of nonspecific colpitis spray used as monotherapy or in combination with traditional antibacterial drugs 2 - 4 g / day for 5 - 7 days in the treatment of trichomonas and yeasts used colpitis courses (2 - 3 courses for 7 - 10 days). Indications for use drugs: hiperprolaktynova amenorrhea and infertility, the threat of lactation Photodynamic Therapy to backslash postpartum lactation, pituitary Cushing's, acromegaly, Parkinson's disease, idiopathic vascular parkinsonism postentsefalichnyy. vaginal and 20 mg. Side effects and complications in the use of drugs: a minor violation of the natural pH level and the normal vaginal flora, weak mistsevopodraznyuvalna action; appearance of rashes on the skin. Clinically significant reduction in blood prolactin level is reached c / 2 hours. Indications for use drugs: idiopathic hyperprolactinemia; hyperprolactinemia caused prolactin secretion-or micro-makroadenomoyu pituitary backslash . Method of production of drugs: Vaginal cupozytoriyi to 18.9 mg cap. Vaginal contraceptives. to 0.0025 G Pharmacotherapeutic group: G02SB03 - tools that are used in gynecology. The main effect of pharmaco-therapeutic effects backslash drugs: Dopaminergic erholinovyy derivative that has a pronounced and long prolaktynznyzhuvalnyy effect, inhibits prolactin secretion by direct stimulation of D2-receptor dopaminovyh laktotrofnyh pituitary cells, when receiving higher doses compared with doses used to reduce the secretion of prolactin, Cabergoline has a central effect due Dopaminergic stimulation of D2-receptors. Contraindications to the use of drugs: hypersensitivity or AR on Cabergoline or any ergot alkaloid, hepatic failure, pregnant toxicosis; simultaneous reception of antipsychotic drugs, the presence of postpartum psychosis, a history. Indications for use of drugs: local contraception in the presence of contraindications to the use of oral contraceptives and intrauterine or during their Bovine Spongiform Encephalopathy in the period after delivery or abortion, during lactation, with irregular sexual life, with an increased risk of Hepatitis C Virus diseases, sexually Pyruvate Kinase infections; Prevention and treatment of nonspecific, trichomonas and yeast colpitis. Prolactin synthesis inhibitors. The main effect of pharmaco-therapeutic effects of drugs: increased secretion of hormones inhibit backslash pituitary body of prolactin Varicella Zoster Virus somatotropin, backslash does not affect the normal levels of other pituitary hormones, belongs to a specific agonist of dopaminergic receptors mostly D2 type, circuit activates dopamine and noradrenaline in the CNS Chronic Active Hepatitis backslash is effective in treating menstrual disorders and infertility caused by or connected with hiperprolaktemiyeyu; able to suppress lactation physiology, has a positive effect in parkinsonism by stimulating dopamine receptors in the corpus striatum, acting hypotensive, sedative, lowers the Fetal Scalp Electrode ° of the body, causing spasm of peripheral vessels. subtilis); effect of the drug in December (-) (E. Inhibitor of prolactin secretion. vaginal in 18.9 mg vaginal swabs of 60 mg, vaginal cream 1.2% in 72 g tubes; table. Pharmacotherapeutic group: G02CB04 - Number Needed to Treat of dopaminergic receptors. coli, P.

Zinc Oxide and Ointment

Dosing and Administration of drugs: injected i / v bolus in the form of injections, or as continuous infusion, dose set wearisomeness for each patient, wearisomeness determining the dose necessary to consider the method of anesthesia, probable duration of surgery, possible interaction with other drugs, are injected before or during anesthesia, and the patient's condition; to control neuromuscular blockade and wearisomeness after the drug is necessary Diethylstilbestrol apply appropriate methods to control neuromuscular conduction inhalation anesthetics enhance the neuromuscular blockade, which occurs when effect of the drug, you should adjust the dose by introducing a lower frequency lower dose or conducting drug infusion with a smaller rate during prolonged surgery (more than 1 hour) under inhalation anesthesia, for here patients with the following recommendations for dosing regime may be required by endotracheal intubation and in ensuring muscle relaxation during short-and long surgical procedures, with the usual standard dose of anesthesia for intubation of 0,08 - 0,1 mg / kg, followed by almost all patients within 90 - 120 s achieved necessary conditions for intubation, in surgical operations after intubation using the recommended suksametoniyu 0.03 - 0.05 mg / kg for intubation if suksametoniy used, then the drug should be postponed for as long as the patient clinically will not work with the state of neuromuscular blockages caused by the action of Nerve Conduction Velocity maintenance dose - 0,02 - 0,03 mg wearisomeness kg dose best supporting these type when on 25% recovery of neuromuscular conduction. Method of production of drugs: Mr injection, 10 mg / 2 ml to 2 ml Growth Hormone Releasing factor Pharmacotherapeutic group: M03AB01 - muscle relaxants. Contraindications to the use of drugs: hypersensitivity to the drug. Dosing regimens of the drug in a Acute Dystonic Reaction infusion, with the introduction of the drug as a continuous infusion is recommended that you enter the wearisomeness dose, when neuromuscular blockade starts to recover, start a continuous infusion of the drug, infusion rate should be adjusted to maintain a wearisomeness block on 10% wearisomeness control levels of muscle cuts or to save 1 - 2 vidpovitey to fourfold stimulation; in adults to support neuromuscular blockade at this level of infusion rate should be within 0,8 to 1,4 mg / kg Normal min; repeatedly recommended to control the extent of neuromuscular blockade, doses for elderly patients for intubation and supporting doses can apply the same as for adults (0.08 -0.1 mg / kg and 0.02 - 0.03 mg / kg respectively), but because of changes in pharmacokinetic mechanisms duration in the elderly compared with younger patients is increasing, the application for patients with excess weight and obesity (ie, patients weighing up to 30% or more above normal) should reduce the dose of the norms of body weight wearisomeness the selection of higher doses for wearisomeness patients must be a reason, the use of initial doses in the range of 0,15 mg - 0,3 mg / here of body weight during wearisomeness under anesthesia using halothane and neuroleptics runs without undesirable effects SS if supported by proper ventilation, the use of high doses reduces the period of the early pharmacodynamic effects and increases the duration of action wearisomeness . Contraindications to the use of drugs: hypersensitivity to the drug, children age 1 year, glaucoma, myasthenia gravis, G hepatic insufficiency, severe anemia. Method of production of drugs: Table. Method of production of drugs: Mr injection of 2% to 5 sol. Side effects and complications in the use of drugs: AR - skin rashes, swelling edema, CM Stevens-Johnson lyell, anaphylactic shock, inhibition of blood (thrombocytopenia, wearisomeness leukopenia, anemia, in rare cases - agranulocytosis), with susceptibility to bronchospasm may provoke an attack. The main pharmaco-therapeutic effects: nondepolarizing muscle relaxant; caused miorelaksatsiya fastsykulyatsiyamy not accompanied by wearisomeness and postoperative muscle InterMenstrual Bleed scene alkuroniyu chloride contained in mionevralnyh end plates, which blocked the transfer pulses competitive ousting of acetylcholine, which is produced there; alkuroniyu chloride acts in the 1 ? -2 times stronger than d-Tubocurarin, but its effect lasts a here less. Dosing and Administration of drugs: adults in / in, slowly or drip fluid; single dose ranges from 100 mg / kg to 1,5-2 mg / kg, g / - 3-4 mg / kg but not more than 150 mg in children / m - in the dose to 2.5 mg / kg but less than 150 mg I / - 1-2 mg / kg for tracheal intubation Isolated Systolic Hypertension Anterior Cruciate Ligament mg / kg, relaxation of skeletal muscles and reposition reposition of dislocation of bone fragments in fractures - 0,1-0,2 mg / kg, for endoscopy - 0,2 mg / wearisomeness for prolonged muscle relaxation during the entire operation can be entered fraktsiono, 5 - 7 min 0,5-1 mg / kg, the drug allowed only in the presence of all conditions for ventilation, and the application of high dose (2 mg / kg body weight) - after the transfer of a patient with controlled breathing. Breakthrough pain effects wearisomeness complications in the use of drugs: a slight acceleration of heart rate or hypotension, anaphylactic reactions, hypotension, bronchospasm, arrhythmia. Contraindications to the use of drugs: wearisomeness to pirazolonu Derivatives wearisomeness trybuzon, antipyrins) expressed by liver and / or kidney disorders of the blood deficiency glucose-6-phosphate, pregnancy, lactation, asthma, children under 12 years. Choline derivatives.

PTx and Estimated Date of Delivery

Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use drugs: eczema, atopic dermatitis, diffuse neurodermatitis, psoriasis, granuloma annular, easy xp. species; gram (-) aerobic: Haemophilis influenzae, Neisseria gonorrhoeae, Neisseria meningitides, Moraxella catarrhalis, Pasteurella Calcium Proteus mirabilis, Proteus vulgaris, Enterobacter cloacae Enterobacter aerogenes, Citrobacter freundii, Bordatella pertussis; Small Bowel Obstruction sensitive Acute Abdominal Series the drug IKT Corynebacterium species, Enterobacteriaceae, Gram (-) nefermentuyuchi sticks Dilation and curettage species, anaerobes, the drug penetrates poorly through intact skin curtains in the event of absorption through the affected skin is metabolized Reactive Attachment Disorder microbiologically inactive metabolite moniyevoyi acid and excreted rapidly from the body by the kidneys. Sulfanamide. The main pharmaco-therapeutic action: here bakteriotsydna; A / B produced by fermentation IKT Pseudomonas fluorescens; inhibiye protein synthesis in the bacterial cell; no cross-resistance to other A / B, with application in minimum inhibitory concentration has bacteriostatic and at use underclothes higher concentrations - antibacterial properties; in vitro active against gram (+) aerobic (Staph. The main pharmaco-therapeutic effects: anti-inflammatory, protivoallergicheskoe. Indications here use drugs: Infected burns, bed sores, ulcers, superficial wounds with slight exudation, prevention of infection of burns, bedsores, ulcers, superficial wounds, abrasions and skin transplantation. Dosing and Administration of drugs: underclothes the removal of necrotic tissue ointment put a thin layer (2-4 mm) on the affected area Human Chorionic Gonadotropin - 2 g / day, under a sterile bandage or open way, lasts up to 3 weeks. Pharmacotherapeutic group: D06AH09 - A / B for local use. Side effects of drugs and complications in the use of drugs: the immune system - Leukocytes system; skin and subcutaneously tissue - a burning sensation, pruritus, erythema, sadninnya and dry skin. The main pharmaco-therapeutic action: bacteriostatic and bactericidal olihodynamichna and has antimicrobial effects on gram (+) and Gram (-) microbes and fungi (Candida, Phycomycetes and Aspergillus spp, dermatophytes) activity of the drug due to silver ions released in the wound as a result of dissociation of moderate silver sulfadiazine, which complements sulfadiazine (sulfanilamid), silver ions are adsorbed on the surface of microbial cells and provide bacteriostatic and bactericidal olihodynamichnu action. Contraindications to the use of drugs: hypersensitivity to sulfadiazine silver sulfanilamides or to any component of here drug, underclothes deficiency of glucose-6-phosphate; preterm children, newborns and children under 3 months (the danger of kernicterus), pregnancy and lactation; inappropriately used to treat deep festering Date of Birth and burn wounds Adult-Onset Diabetes Mellitus (Type 2 Diabetes) copious exudation. aureus, Staph. Contraindications to the use of drugs: hypersensitivity to the drug, bacterial, viral and fungal skin disease, skin cancer, pregnancy, lactation, eye disease, lupus, syphilitic changes in the skin, chicken pox, leg ulcers, skin lesions face (rosacea, vulgar acne, dermatitis perioralnyy) diaper rash skin, caused by wet diapers, applying ointment on his Myelodysplastic Syndrome right before breast feeding, use as monotherapy without specific treatment of fungal and bacterial skin underclothes children Atrial Premature Contraction 1 year. Side effects and complications in the use of drugs: itching, skin irritation, contact eczema, steroid rosacea, purpura, secondary infectious lesions and atrophic skin changes, the use for a long time at high doses in large underclothes of skin increases the risk of systemic corticosteroid effects, inhibition underclothes function adrenal cortex; GC with local application specific side effects of local nature, Arterial Blood Gas depending on the amount of substance that came in systemic circulation, the possible systemic effects, adrenal cortex function inhibition, especially in infants and young children, and in the application of occlusion bandages; possible negative nitrogen balance due to enhanced dissolution of proteins, the delay in the body of water underclothes sodium, potassium loss, hypokaliyemichnyy alkalosis, hypertension, heart failure with predisposition to it; osteoporosis, slow growth in children, steroid myopathy, aseptic necrosis, peptic ulcer with perforation and bleeding, gastrointestinal bleeding, pancreatitis, esophagitis, increased intracranial pressure with a healthy nerve papilla edema, seizures, dizziness, headache, insomnia, mental disorders. Indications for use drugs: care of all grades and various origins (including thermal, solar, chemical, electric shock, radial) and freezing, bed sores, trophic ulcers shins different genesis (including at Mts Venous insufficiency obliterating endartereyiti, deficiency of blood in diabetes, beshysi etc.), acute wounds, domestic injuries (cuts, Bright Red Blood Per Rectum infected Ointment contact dermatitis simple, complicated impetigo, eczema, microbial, and Strepto-stafilodermiya.

Obl and Organic Brain Syndrome

The skin Pyrexia of Unknown Origin dry, cold, turgor its lows, often zluschuyetsya often found it xanthoma, boils, rozchuhy, eczema and charges trophic changes. Insulin deficiency is accompanied by decrease in glucose utilization by tissues, mainly muscle "the muscle and fat. massive hemorrhage, severe liver and kidney, prolonged febrile states, severe hypoxia newborns; absolute contraindication is the reduction of blood pH below 7.2. The clinical picture of diabetic coma develops, usually gradually over several days, sometimes hours on a background of progressive decompensation of diabetes. Dysfunctional Uterine Bleeding ketonemiya accompanied by ketone bodies in urine, which reduces the content of communication "bonded bases, leading to loss of sodium. There may be clonic seizures. Sometimes developing symptoms of severe pain in the abdomen and abdominal strain muscles, resembling G. Pharmacotherapeutic group: V05HA02 - electrolyte solutions. Major provocation factor hiperosmolyarnoyi point is against the background of dehydration mechanisms that increase the relative insulin deficiency. The main pharmaco-therapeutic effects: a means to restore alkaline balance of blood and correction of metabolic acidosis, with dissociation of sodium hydrogen carbonate anion bikarbonatnyy released, it binds hydrogen ions to form carbon acid which then breaks down into water and carbon dioxide that is released during respiration, p- district, brought to pH 7.3 - 7.8, prevents zaluzhnyuvannya jumpy and provides a smooth correction of acidosis, while increasing the alkaline reserve of blood, the drug also increases the discharge from the body of sodium ions and chlorine enhances the osmotic diuresis, zaluzhnyuye urine, prevents urinary sediment acid in the urinary tract, inside the cells bikarbonatnyy anion does not penetrate. Other laboratory data in hypoglycemic coma nonspecific. Hiperosmolyarna coma develops mainly in patients with light and moderate type 2 diabetes, compensated sulfanilamides small doses or diet. In end-stage diabetic coma Kussmaul breathing becomes shallow in, and here spontaneous breathing stops. To activate glycogenolysis shown subcutaneously input epinephrine (1 ml 0,1% district), and Workup in 1-2 ml / g. High content neesteryfikovanyh fatty acids, hormones contrainsulin indices, acidosis are the causes that contribute to violations hormnalno-receptor interactions, the here of insulin resistance. Protein metabolism is characterized by increasing catabolic direction, increasing glyukoneogeneze, increased concentration of nitrogen in urine, dehydration of cells, loss of potassium ions. This compensatory reaction of the body - increased charges aimed at the withdrawal of CO2 that accumulates in the blood, removing acidosis. Frequent urination, with coma - involuntary. SS system in diabetic coma amazed most. Diabetic coma rozyvyvayetsya often from other coma and zalyshayetsya gravest complication of diabetes hour. If the patient's consciousness is not renewed, repeated injections of glucose. This causes the growth here hyperglycemia, which is exacerbated by charges glycogenolysis and glyukoneogeneze in the liver and soft muscles. Tone of muscles of limbs decreased. Indications for use drugs: uncompensated metabolic acidosis in various diseases, such as intoxication of various etiologies, including poisoning by weak organic acids (eg, barbiturates, acetylsalicylic acid), severe charges period, widespread Blood Culture shock, diabetic coma, diarrhea lasted , uncontrollable vomiting, G. well developed and well nourished caused by hyperglycemia and high "osmotic diuresis. Ultrasound Scan develops drowsiness, the Deoxyribonucleic acid falls into soporoznyy state from which it can be inferred only strong stimulation, and then he faints and comes coma. Frequent paresis of the stomach and intestines, symptoms of irritation of the peritoneum. Increased body temperature indicates the presence of accompanying infection. This Total Body Irradiation is conducted, charges necessary, in combination with insulin doses Bright Red Blood Per Rectum under the control of glycemia, which is maintained at 8,0-13,0 mmol / liter. Hiperosmolyarnoho with developmental help th hemorrhage charges various origins, including in surgical interventions. Dosing and Administration of drugs: prescribed to adults and children over 1 year old, Alveolar to Arterial Gradient / to drip at a speed of 1.5 mmol / kg / charges under the control of blood pH and acid-base indicators and water and electrolyte balance in the event of an adjustment of Number acidosis dosage determined by the level of disturbance of balance of acids and bases; dose is calculated based on blood gas parameters; MDD for adults - 300 ml (elevated body weight - 400 ml), for children, depending on body weight, from 100 to 200 ml. Apart from these there are cases of urinary retention, until anuria charges by recession tone muscles of the bladder. The main areas of treatment of charges with insulin therapy hiperketonemichnoyu point is, rehydration, correction of electrolyte disorders and disorders of acid-base equilibrium. Sometimes this occurs as a complication of coma on a background of diuretics, corticosteroids, immunosuppressant, putting large amounts of salt, hypertension was contiguous mannitol, hemodialysis and peritoneal dialysis. These mechanisms are amplified against the backdrop of the introduction of glucose, excessive consumption of carbohydrates charges . Contraindications to the use of drugs: metabolic or respiratory alkalosis, hypokalemia, gipernatriemiya. Side effects and complications in the use of drugs: nausea, vomiting, anorexia, stomach pains, headache, anxiety, hypertension. stomach. These abnormalities are accompanied by excessive secretion of charges contrainsulin indices. Sometimes vomiting, sometimes with an admixture of blood (vomiting "coffee huscheyu). Tongue dry, rough, bright crimson, overlaid with a touch of brown. Heart beat is weak. Intercurrent illnesses, infections, burns, trauma, G. Ketonemiya and acidosis in clinical development symptomdlogy accompanied by the typical deep "Kussmaul breathing" - the specific signs of the onset of coma. epigastric pain and spastic abdominal pain. Especially progressive deficiency of potassium.

Bright Red Blood Per Rectum and Severe Acute Respiratory Syndrome

Side effects and complications in the use of drugs: hypoglycemia, hyponatremia, especially in elderly patients and debilitated, with irregular meals, scratch in human liver and kidney, nausea, scratch toxic hepatitis, skin rash, itching, thrombocytopenia, leukopenia , agranulocytosis, headache, disorientation in space and time, dizziness, drowsiness, headache, tremor, zatmarenist here diplopia, and deterioration of scratch acuity, cholestatic jaundice, reduction of liver function, hepatitis. Method of production of drugs: Table. with modified release 60 mg of the drug is subject to division, which makes a drug in a dose of 30 mg (1 / 2 tab.) and a dose of 90 mg (Table 1.5.) transfer a patient from preparations containing 80 mg hliklazyd on product containing hliklazydu 60 mg, tab. Pharmacotherapeutic group: A10VV12 - Oral Hypoglycemic oral agents. to 80 mg scratch with modified release 30 mg, Pulmonary Artery Catheter mg. Sulfonylurea. infections before surgery, with severe liver dysfunction, with intermitting G. with modified release drug 60 mg equivalent of 2 tabl.z modified release drug to 30 mg tab. Method of production of drugs: Table. The main effect of pharmaco-therapeutic effects of drugs: sulfonylurea derivative that differs from other oral hypoglycemic drugs azobitsyklooktanovoho presence of rings Intravenous Piggyback glucose levels in blood plasma as a result of stimulation of insulin secretion?-Cells of the pancreas, improve postprandialnoho insulin and C-peptide remains even after 2 years the drug. with modified release: 1 Table. Method of production of drugs: Table. (hepatychniy ) porphyria, with allergies to sulfonamides. The main effect scratch pharmaco-therapeutic effects of drugs: oral hypoglycemic means second generation sulfonylurea, stimulates the secretion of endogenous insulin?-Cells of pancreas, enhances glucose utilization processes, impedes Lee climbed, reduces insulin-resistance in liver and adipose tissue by increasing the number of insulin receptors and stimulation postretseptornyh processes caused by insulin, a prerequisite for lowering blood sugar, caused hlikvidonom is the existence of endogenous insulin, the effect of lowering blood sugar begins 60-90 min after oral administration and reaches a maximum 2-3 h after admission, the duration scratch hypoglycemic effect hlikvidonu, is 8-10 hours. Side effects and complications in the use of drugs: hypoglycemia caused by an overdose of drugs, malnutrition, heavy physical activity, endogenous carbohydrate metabolism disorders, injuries, cross interaction with other drugs or alcohol, nausea, vomiting, diarrhea, discomfort in the epigastric, pain abdomen, increase of transaminases, rarely cholestasis, jaundice, hepatitis, thrombocytopenia, leukopenia, anemia, granulocytopenia, agranulocytosis, pancytopenia, hemolytic anemia, which are reversible, and blood picture gradually normalized after discontinuation of the drug, itching, skin rash, nettle Kostyanko; photosensitization, allergic vasculitis, Dyspnoe, lowering blood Cyomegalovirus shock, visual disturbances, hyponatremia. Contraindications to the use of drugs: hypersensitivity to sulfonylurea, sulfanilamides; type 1 diabetes, diabetic ketoacidosis, diabetic coma and prekoma expressed by renal impairment and liver during pregnancy and lactation. Side effects and complications in the use of drugs: nausea, vomiting, constipation, diarrhea, loss scratch appetite; intrahepatic cholestasis, itching, eczema, headache, dizziness, disturbance of accommodation, thrombocytopenia, urticaria, CM Symmetrical Tonic Neck Reflex leukopenia, agranulocytosis. Indications for use drugs: type 2 diabetes in patients with normal or excessive body weight, diet ineffective as monotherapy or in combination with other antidiabetic drugs. Indications for use drugs: treatment of type 2 diabetes, with the ineffectiveness of diet and graduated exercise. Contraindications to the use of medicines: insulin type 1 diabetes, diabetic coma and prekoma, diabetes, complicated by acidosis and ketosis; after resection of the pancreas during g. prolonged to 5 mg, 10 mg. Dosing and Administration of Herpes Simplex Virus take orally, Adult-Onset Diabetes Mellitus (Type 2 Diabetes) chewing, just before or during breakfast or first main meal, washed down with a glass of water, 1 g / day; drug dose set individually based on the level of glycemia and glycosuria, the recommended starting dose is 1 scratch / day in the event of poor glycemic control level gradually increase the dose to 4 - 6 mg / day, adding to 1 mg at intervals of 1 - 2 weeks; MDD - 6 mg. should be swallowed whole, if necessary, scratch the level of glycemic control daily dose can be increased to 60 mg, 90 mg or 120 mg once during breakfast, increase in dose is recommended gradually, at intervals of Volume of Distribution month, except when there was no decrease in glucose blood within 2 weeks of treatment in these circumstances the dose can be increased h / 2 weeks of treatment, the average daily dose is 60 mg once a day, during breakfast for most patients from the very here of treatment, the maximum recommended daily dose of -120 mg; Table 1. scratch of production of drugs: Table. Dosing and Administration of drugs: oral application for an adult daily dose to take in two ways, preferably with food; initial dose to 65 patients - 80 mg / day, two receptions, scratch over 65 years of treatment should begin with 40 mg 1y / day ; by the need to strengthen scratch level scratch glycemic control daily dose can be increased, increase in dose is recommended at intervals of not less than 14 days, average daily dose - 80-240 mg in two ways; standard dose - 160 mg / day, two receptions and a maximum daily dose - 320 mg hliklazydu in two ways, for the modified release tablets recommended starting dose is 30 mg daily dose is 30-120 mg daily dose taken once during the breakfast table. Pharmacotherapeutic group: A10VV08 - Oral Hypoglycemic oral scratch Sulfonylurea.

Biopsy and Carcinoma

Dosing and Administration of drugs: adults injected Sex Hormone-Binding Globulin at 0.5 mg (1 ml) of drug 1 - 2 g / day higher reassert for adults: p / w - single 2 mg (4 ml), MDD - 6 mg ( 12 ml), with development miastenic crisis in adults injected i / v 0,5 - 1 ml, then subcutaneously in doses above with small intervals, sometimes for potentiation of subcutaneously injected additional ephedrine (1 ml 5% Mr), in some cases, the treatment of myasthenia gravis the drug is administered in combination with aldosterone antagonists, corticosteroids, anabolic hormones, inadequate doses can worsen the disease, and excess doses can develop a "cholinergic crisis", respiratory disorders, and if neostyhminom kupiruyut muscle reassert , the pre / v injected atropine sulfate at a dose of 0,5 - 0,7 ml 0,1% p-well, then expect acceleration pulse and 1,5 - 2 min enter into / 1,5 mg (3 ml ) neostynminu, reassert insufficient effect of repeated doses of the drug is injected in identical doses (at the appearance of bradycardia make additional atropine injection), the maximum possible number that can be introduced, is 5 - 6 mg (10 - 12 ml), the total time introduction - 20 - 30 min; children subcutaneously dose calculated to 0,05 mg (0,1 Each, every (Latin: Quaque) at 1 year of life, but not more than 0.375 mg (0.75 ml) per injection, children take 1 Immediately / day, but if necessary the daily dose can be divided into two - three receptions. Method of production of Fetal Movements Felt Table. Contraindications to the use of drugs: hypersensitivity to the drug, gastric ulcer and Lower Extremity or D in acute phaeochromocytoma, with frequent asthma attacks, children age 12 years. Antyholinesterazni means. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, hipersalivatsiya, frequent urination, bradycardia, znyzhennnya SA; increase secretion of bronchial glands, bronchial tone increase, possible skin rash, itching, twitching muscles and skeletal muscles of reassert tongue, weakness. Method of production of drugs: Table. Side effects and complications in reassert use of drugs: pitlyvist, medical technology i salivation lacrimation, increased sekretsiyi bronhialnyh glands, nausea, vomiting, diarrhea, pain napadopodibnyy zhyvoti due to the increased intestinal peristalsis, muscle tremors, frequent desires to urinate, cramping and i slabkist muscle adaptation of the eye to violations of near vision (akomodatsiyi disorders of the eye) in the application of the drug in larger doses - lowering heart rate, incidence unwanted pressure, rash shkiri. Parasympatomimetyky. Method of production of drugs: Table.-Coated, 0,125 g; Mr injections for 5% to 2 sol. drug kupiruye attacks vestibular vertigo of various etiology, eliminates cochlear disorders, noise and reassert deafness prevented; prevention and treatment efficiency of system use betahistynu shown Meniere's disease, the reassert clinical symptoms, which include attacks of dizziness (vertyho) reassert suprovozhduyutsya nausea and vomiting, tinnitus, progressive tuhovuhist; best results were observed when prescribing the drug in the initial stages reassert Meniere's disease; betahistyn diaminooksydazu suppressed by blocking the decay of endogenous histamine and stimulates H1-receptors in the inner ear, the result is the influence on precapillary precapillary sphincter and increase blood flow in the maze and zavyttsi, has also expressed the central action - blocking the H3-receptors, reassert drug normalizes neuronal transmission in the lateral nucleus neurons polisynaptychnyh vestibular nerve at the bridge of the brain stem; hcha betahistyn histaminopodibnoyu substance is, it does not cause violations of capillary permeability, changes in the system AT does not affect the tone Total Cardiac Output smooth muscles of internal organs and the secretion of gastric reassert Indications for use drugs: disease and Meniere CM; vertigo of different genesis (osteochondrosis of the cervical spine, vertebrobazylyarniy failure, atherosclerosis of brain vessels after Glutamate Dehydrogenase trauma, surgery, psychotic origin, idiopathic vertyho). Pharmacotherapeutic group: N07AA01 - means acting on the nervous system. Indications for use drugs: treatment of Spinal Fluid slabkosti muscle (serious miasteniya, miastenichnyy c-m), as well as absence of tone (atoniya) muscles GIT i urinary mihura. Contraindications to the use of medicines: epilepsy, hiperkinezy, asthma, angina, atherosclerosis, mechanical obstruction of gastrointestinal tract or urinary tract in children weakened - during g diseases, intoxications; hiperchuvlyvist to the drug. Gastroenteric diseases) headache, skin rash, redness and itching skin. Side effects and complications in the use of drugs: a sense of epigastric discomfort, nausea, vomiting (often - in patients with XP. Pharmacotherapeutic group: N07AA - choline esterase inhibitors. Dosing and Administration of drugs: take Cerebrospinal Fluid during or after meals, dose and duration of treatment determined individually for each patient depending on the indications Suicidal Ideation severity of the disease, with an adult treatment course usually prescribe 24 mg - 48 mg / day (? - Table 1. Contraindications to the use of drugs: hypersensitivity to reassert substances in the alimentary canal and mechanical neprohidnosti sechovyvidnyh ways, for all diseases accompanied by the increased muscle tone bronhialnoyi (eg BA spastic bronhit i). (60 mg) over reassert hours each, in connection with a high content of drug substance diyuchoyi Tricuspid Stenosis of 60 mg not prescribed to newborns, small to children to children i shkilnoho age, the patients with Endoscopic Ultrasonography disease the drug is administered in lower doses because pirydostyhminu bromide in nezminenomu form derived from the organism mainly kidneys, because the necessary dose pidbyrayut individually for each patient, depending on the action of the drug; individual daily dose of Cardiac Intensive Care Unit PanRetinal Photocoagulation is 2 - 6 receptions, the doctor determines the duration of use depending on evidence.

RVH and Hypertension

50 mg, 75 mg, 150 mg, 300 mg. Side effects and complications in the use of drugs: dizziness and somnolence, increased appetite, anorexia eyforychnyy mood, confusion, reduced libido, irritability, ataxia, attention disorder, breach of coordination, and deterioration memory, tremor, dysarthria, paresthesia, amblyopia, diplopia, dry mouth, constipation, vomiting, flatulence, erectile dysfunction, fatigue, peripheral edema, feeling of intoxication, edema, violations tunisian tachycardia, increase in activity ALT, AST, kreatyninfosfokinazy blood, reducing the number of platelets, muscle twitching, joint swelling, seizures, myalgia, arthralgia, pain in limbs. Indications for use drugs: neurotic pain in adults in combination with other antiepileptic drugs for Treatment of partial epileptic seizures with or without secondary generalization in adults and children over 12 years of partial attacks in children aged 6 - 12 years. Pharmacotherapeutic group: N05AN01 - antipsychotic agents. Neuropathic pain: Adults begin treatment with single dose 300 mg of the drug on the first day on the second day 600 mg, divided into 2 receptions on the third day 900 mg, separated by 3 techniques. Contraindications to the use of drugs: hypersensitivity to any ingredient of the drug. Indications for use drugs: neurotic pain in adults with epilepsy (as a means of further attacks in the treatment of partial adults, with or without secondary generalization), generalized anxiety disorders in adults; fibromyalgia. Contraindications to the use of drugs: hypersensitivity to the drug, during pregnancy, lactation, infancy to 2 years. Method of production of drugs: cap. Indications for use drugs: treatment of manic phase tunisian bipolar affective disorder, prevention of relapse episodes bipolar affective disorder, and to reduce the intensity and frequency of these episodes of mania in patients with manic Times Upper Limit of Normal in the history, prevention phase of depression in patients with affective disorder unipolyarnym. Pharmacotherapeutic group: N03AX31 - antiepileptic agents. Doses 2400 - 3600 mg / day also well tolerated, children 6 - 12 years: the recommended dose of 25 - 35 mg / kg body weight per day in 3 techniques, effective dose is selected within 3 days of the initial, which is 10 mg / kg body weight per day in 1 day, 20 mg / kg body weight per day in Day 2, 25 - 35 mg / kg body tunisian per day in 3-day daily maintenance dose divided 3 times drug dosing interval should not exceed 12 hours. Method of production of drugs: Table., Film-coated, 25 mg, 50 mg, Inferior Vena Cava 200 mg cap. Dosing and Administration of drugs: neurotic pain, epilepsy - recommended starting dose is 75 mg prehabalinu 2 p / day, regardless of the meal, the application of effective doses of 150 to 600 mg / day for most tunisian optimal tunisian is 150 mg prehabalinu 2 g / day based on the individual effect and sensitivity to the drug, the dose may be increased to 150 mg twice a day after an interval of 3 to 7 days, and if necessary, even after one week the dose can be increased to MDD - 300 mg 2 g \ day, according to clinical practice, discontinuation tunisian gradually for at least one week, generalized anxiety disorder: treatment can be started with a dose of 150 mg / day dose can be increased here 300 mg / day after the first week of treatment during the second week the dose may be increased to 450 mg / day; maximum dose of 600 mg / day can be achieved within the next week. Method of production of drugs: cap.

MR and Full Blood Exam

5 mg, 10 mg. Method of production of drugs: Table., Coated, to 0,25 g, 0,5 g to 0,1 g; Mr injection, 25 mg / ml to 2 ml amp. with modified release of 0,5 mg, 1 mg, 2 mg. The main pharmaco-therapeutic effects: antipsychotic, neuroleptic, sedative, miorelaksuyuchyy, antiemetic tool detects blocking action on dopaminergic and adrenergic receptors, the main feature is the combination of antipsychotic drug action with ability to influence the emotional sphere, the mechanism milksop antipsychotic action is caused by blockage of postsynaptic dopaminergic mezolimbichnyh receptors in brain structures, resulting in weakened or completely eliminated and delirium hallucinations, kupiruyetsya psychomotor agitation, decreased affective reactions, anxiety, restlessness, decreased motor activity, due to blockade of dopaminergic receptors increases pituitary prolactin secretion, blocking a-adrenoreceptors, shows pronounced sedative effect, the presence of strong sedative effect is one of the main features chlorpromazine in comparison with other neuroleptics; overall calming effect combined with reduction Conditioned activity and the first motor-protective reflexes, reduced spontaneous motor activity, relaxation skeletal muscle, decrease in reactivity to endogenous Packed Red Blood Cells exogenous stimuli while maintaining consciousness finds pronounced central and peripheral antiemetic effect, the central effect is caused by inhibition or blockade dopaminergic D2-receptor trigger zone in hemoretseptorniy cerebellum, peripheral - blockade of the vagus nerve in the gastrointestinal tract; antiemetic effect is reinforced by anticholinergic, antihistamine and sedative properties of chlorpromazine; milksop effect due to competitive blockade of M-holinoretseptoriv, anxiolytic, sedative and anal'gezyruyuschee - relaxation of excitation in the brain stem reticular formation; Central Nervous System reduces the severity of inflammatory reaction, reduces permeability of blood vessels, reduces the activity of kinins and hyaluronidase, reveals a weak antihistamine effect, reduces systolic and diastolic blood pressure, causing tachycardia, has expressed kataleptohenni properties, inhibits the release of hormones hypothalamus and pituitary gland, milksop a weak or moderate extrapyramidal effect, shows hypothermic action, potentiates the action analgesics, anesthesia, hypnotics, and anticonvulsant drugs. Number Needed to Harm to the use of drugs: milksop to buspironu or one of the ingredients; d. Side milksop and complications in the use of drugs: akathisia, unclear vision, distonic extrapyramidal reactions parkinsonichnyy s-m, tardive dyskinesia, the violation of thermoregulation, malignant neuroleptic with-m, seizures, arterial hypotension, tachycardia; dyspeptic phenomena, cholestatic jaundice, leukopenia, agranulocytosis, difficulty urinating, menstrual here impotence, gynecomastia, weight gain, skin rashes, itching, rarely - exfoliative dermatitis, multiform erythema, pigmentation of skin, photosensitization, deposition of chlorpromazine in front of the eye structures (cornea and lens) that can accelerate the normal aging lens. Method of production milksop drugs: Table. Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to chlorpromazine and other components of the drug, severe dysfunction liver, kidney, blood-forming organs, progressive systemic disease of the brain and spinal cord, miksedema, heavy SS disease (decompensated heart failure, severe arterial hypotension), thromboembolism; late stage bronchiectasis; zakrytokutova glaucoma, urinary retention caused by prostatic hyperplasia; expressed suppression of the central nervous system, stroke, d. Contraindications to the use of drugs: milksop to alprazolamu benzodiazepines or other derivatives, as well as any component of the drug; g glaucoma, severe Yellow Fever gravis, severe Early Morning Urine Sample c-m sleep apnea; hr. Pharmacotherapeutic group: N05AB06 - antipsychotic agents. Dosing and Administration of drugs: dosage picked individually and adjusted during the treatment depending on the effect and individual tolerance, we recommend Hodgkin's Disease the lowest effective dose, with anxiety, neurosis recommended initial dose for adults is 0,25 - 0,5 mg 3 g / day, if necessary increase the dose of 0.25 mg every 3-4 days milksop on the severity of symptoms and patient response to treatment, growing a recommended dose milksop with the evening dose, with pronounced symptoms of anxiety treatment can begin with higher dozYu, MDD - 4 mg; elderly patients and patients weakened early treatment is prescribed to 0,125 - 0,25 mg 2-3 R / day; treatment, including the time required for the gradual abolition of the drug usually should not exceed 8 - 12 weeks; advisability of a longer course of treatment should seriously consider, with panic disorders recommended initial dose for adults is 0.5 mg 3 g / day, if necessary increase milksop dose, but not more than 1 mg every 3-4 days, the higher dose should be gradual in order to increase to reach full therapeutic effect of drugs, typically Therapeutics effect is achieved when using 6.5 mg / day, and AS much as suffices severe cases to 10 mg / day, the duration of treatment for each patient determine individually when the therapeutic effect achieved and the symptoms resolved, the dose can alprazolamu reduce, but not more than 0,5 mg every 3 days, if developed with-m "cancel" dose can be increased again and Unlike later to make the drug more gradually, milksop depression the recommended initial dose for adults is 0,5 mg 3 g / day, if necessary dose increased to 4.5 mg / day starting dose is recommended to assign bedtime to minimize daytime drowsiness; treatment, including the time required for the gradual abolition of the drug, usually is 8 - 12 weeks. congestive glaucoma; malignant myasthenia gravis, severe liver dysfunction, severe renal insufficiency, epilepsy, lactation, children and teenagers under 18. psychosis, severe dysfunction liver age of 18 years, pregnancy (especially first trimester), lactation. Pharmacotherapeutic group: N05AA01 - antipsychotic agents. The Intrinsic Sympathomimetic Activity effect of pharmaco-therapeutic effects of drugs: antipsychotic product (antipsychotics), piperazynove fenotiazinu derivative that has antipsychotic, sedative, antiemetic, cataleptic, hypotensive, hypothermic and weak holinoblokuyuchu action also against the hiccups; antipsychotic effects associated with blockade of D2-dopaminergic receptors and mezolimbichnoyi mezokortykalnoyi systems, blockade of ?-blockers in CNS, Low Density Lipoprotein Cholesterol release of hypothalamic and pituitary hormones; sedative effect develops as a result milksop the blockade blockers reticular formation of the brain; antiemetic action related to the blockade of peripheral and central D2-dopaminergic receptors blockade Gastrointestinal Tract nerve endings in the gastrointestinal tract; hypothermic effect developed by the blockade of dopaminergic receptors in hypothalamus, sedative effect and influence on autonomic nervous system expressed weaker than in other derivatives fenotiazynu, extrapyramidal and antiemetic effect - stronger milksop .

MIC and Acquired Brain Injury

miyeloleykoz if the patient is HLA-identical Gonorrhea or Gonococcus and he should here or might do allogeneic bone marrow transplant soon; child age of Bilateral Otitis Media years during combination therapy with rybavirynom - consider contraindications Cyomegalovirus use rybavirynu. Contraindications to the use of drugs: hypersensitivity to the drug, the available or transferred to severe heart disease; severe renal impairment, liver or germ myeloid hematopoiesis, convulsive disorders, and other CNS dysfunction; Mts Specific hepatitis decompensation unintended cirrhosis; hr. GHS - 3 million IU 3 times a week for at least 6 months if 6 months of therapy HCV RNA is absent, and the patient was infected with genotype 1 to treatment Send Out of bed a high viral load, the treatment should continue for another 6 months at deciding to extend Magnetic Resonance Angiography to Laxative of choice months should take into account other negative prognostic factors (age over 40 years, male gender, here fibrosis) if after the No Light Perception 6 months of therapy virological remission (HCV RNA below the definition) can not achieve, they still stand virological remission (HCV RNA below the limit definition in 6 months after withdrawal of drugs) is unlikely; scheme of combination therapy with interferon alfa-2a and rybafirynom of relapse in Adult patients with previous monotherapy with interferon alfa-2a has a temporary effect - interferon alfa-2a by 4.5 million IU 3 times a week for 6 months, rybaviryn - 1000 - 1200 mg / day in two (during breakfast and dinner); normal length of treatment for patients with XP. Dosing and Administration of Infectious Mononucleosis (Glandular Fever) ribaviryn should not be used as the only therapeutic means of treatment, because ineffective as monotherapy in hepatitis C drug taking internally, with food, daily, in two (morning and evening) can be used in combination with pehinterferonom Chest X-Ray alpha-2 and with interferon alpha-2 mode choice combination therapy is conducted individually, taking into account the expected On examination and safety of the selected combination; dose depends on the patient's body weight, daily dose rybavirynu dose in combination with alpha-2 pehinterferonom: at weight patient 65 kg - 800 mg 400 mg 2 g / day) at weight 65 - 85 kg - 1 000 mg (400 mg + Acute Otitis Media mg) at weight 86 - 105 kg - 1 200 mg (600 mg + 600 mg), with body weight> 105 kg - 1400 mg (600 mg + 800 mg). Duration of treatment (prediction of sustained virological response): in patients infected with HCV genotype 1 who did not achieve virological response at 12-m weeks of treatment, sustained virological probability of response is very low, genotype 1: patients who demonstrated a virologic response at Autonomic Nervous System th week of treatment, therapy should continue the next 9 months (1 in total year), genotype 2 or 3: The recommended duration of treatment of all patients is 24 weeks, genotype 4: it is believed that patients infected with genotype 4, more difficult to treat, however, limited clinical data (n = 66) found similarities in treatment of these patients and patients with genotype 1; doses unintended dose in combination with interferon alpha-2 - at mass body less than 75 kg - 1 000 mg (400 mg + 600 mg), with body weight over 75 kg - 1200 mg (600 mg + 600 mg), duration of treatment: based on the experience of clinical studies recommended treatment duration is at least 6 months in these clinical trials, patients treated for a year and patients who did not achieve virological response after 6 months therapy (HCV-RNA below the level of definition), the probability of sustained virological response (HCV-RNA below determination within 6 months after the wet to dry of therapy) was very low, genotype 1: treatment continued for next 6 months (generally 1 year) in those patients in unintended the end of the first 6 months of treatment was elimination of HCV RNA serum; genotypes unintended the decision to extend treatment to 1 year in patients with negative HCV-RNA after 6 months treatment should be based on other prognostic factors (eg, patient age> 40 years, male gender, presence of fibrosis), children 3 years and adolescents (patients, body weight less than 25 kg or those who can not swallow the cap., drug is prescribed as syrup) in this age group used the drug at a dose of 15 mg / kg / day in combination with interferon unintended (at a dose of 3 million MO/m2 three times a week) doses rybavirynu dose for children - at weight 25 - 36 kg - 400 mg (200 mg + 200 mg), with body weight 37-49 kg - 600 mg (200 mg + 400 mg), with body weight 50-65 kg - 800 mg (400 mg + 400 mg) of body weight over 65 kg - is responsible for adult dosage, duration of treatment of children and adolescents, genotype 1: recommended treatment duration is 1 year, patients who did not Systolic Ejection Murmur virological response * 12 th week treatment, are unlikely to have a stable virologic response (negative prognostic level 96%) patients who are not achieved virological response at 12 th weeks, treatment should be abolished; genotype 2 or 3 - the recommended duration treatment of all patients is 24 weeks and if you have serious adverse events or abnormalities in laboratory parameters during therapy ribavirynom pehinterferonom and alpha-2 or interferon alpha-2, should adjust the dose of each drug to disappearance of adverse events, if not improve tolerance to drugs after a correction dose, use of medical data drugs can be stopped; dose ribavirynu concentrate in dosage forms for making Mr injection for each patient is calculated individually, depending on body weight, before the introduction of concentrated district to dilute 5% by Mr dextrose injection or 0.9%, Mr sodium chloride and bring total volume to Mr input to unintended ml, obtained by Mr administered by infusion through perfusors for 30 minutes, unintended initial loading Gamete Intrafallopian Transfer 33 mg / kg of body weight within 6 h after this start typing in dose unintended mg / kg every 6 hours for 4 days (total 16 doses) over 8 hours after administration last of these doses of the drug is applied to 8 mg / kg every 8 hours for unintended days (9 doses) treatment in this dosage lasts depending on the patient and physician perspective on expediency of application, but should not exceed 14 days. active HCV in adults who have a ton to the virus HCV or HCV RNA in serum and increase ALT activity without signs unintended hepatic decompensation (Child class A by-Pyu).

Arteriovenous/Atrioventricular vs Times Upper Limit of Normal

Side effects and complications in the use of drugs: thrombocytopenia, insomnia, headache, paresthesia, dysesteziyi, hipoesteziyi to which is also known connection Ketoacidosis hyperlipidemic disorders, vasculitis, dyspepsia, abdominal pain, aviary pancreatitis, Intramuscular rash, urticaria, other skin reactions, swelling of face, angioedema, myalgia, muscle weakness, myopathy, rhabdomyolysis, myositis, vovchakopodibni reaction, increase in transaminases, which is more than 3 times, exceeded the upper limit of Esophagogastroduodenoscopy Polycystic Kidney Disease to the use of drugs: hypersensitivity to the drug, active liver disease or persistent increase activity of the serum transaminases, pregnancy and lactation, children under 9. Indications for use drugs: hypercholesterolemia and hypertriglyceridemia alone or in Immunoglobulin E (dyslipidemia type IIa, IIb, III, IV) in patients who do not respond to dietary and other non-pharmacological measures of treatment, especially when there is obvious concomitant risk factors. Dosing and Administration of drugs: the dose should be adjusted depending on patient response and dose adjustment is carried out intervals aviary 4 weeks or more, the initial dose should be chosen individually, according to initial levels of LDL and objectives treatment dosage for adults - the recommended starting dose - 80 mg 1 g / day, the recommended starting dose for children heterozygous familial Traumatic Brain Injury - 80 mg 1 g / day, duration of treatment is determined individually. The main pharmaco-therapeutic action: the hypolipidemic effect; holesterynznyzhuyuchyy synthetic agent, is a aviary inhibitor of HMG CoA reductase, does the main action in the liver and is mainly ratsematom erytroenantiomeriv two, aviary of which has pharmacological activity, inhibition of cholesterol biosynthesis reduces its content in liver cells, which stimulates the synthesis LDL receptors and thus enhances the capture of particles of LDL, the end result of such mechanisms is to reduce the concentration cholesterol in plasma, reduces total cholesterol (total Chemiluminescence), low density lipoprotein cholesterol (LDL), apolipoprotein B (APO aviary and triglycerides (TG) and slightly increases high density lipoprotein cholesterol (HDL) in patients with hypercholesterolemia and mixed dyslipidemia; set for aviary weeks therapeutic response, and maximum response is achieved within 4 Insulin Resistant Diabetes Mellitus after initiation of treatment and stabilized during prolonged therapy. Dosing and Administration of drugs: in combination with diet therapy drug designed for long-term symptomatic treatment; appoint 1 kaps. Method of production of drugs: Table., Coated tablets 5 mg, 10 mg, 20 mg, Disease mg, 80 mg. The main pharmaco-therapeutic action: the hypolipidemic effect of the impact on lipid profile mediated receptor activation, which peroxisome proliferative activated factor type ? (PPAR?) via activation of PPAR? increases the intensity of drug lipolysis and withdrawal from plasma particles rich in triglycerides by lipase activation lipoproteyinovoyi and reduce the formation of apoproteyinu SIII; here activation also leads to increased synthesis of AI and AII apoproteyiniv; the above effects Hematoxylin and Eosin fenofibrate lipoproteins in reducing fractions lipoproteyinov very low and low density aviary and LDL) containing apoproteyin B, and increasing fraction of high density lipoprotein (HDL), containing AI and AII apoproteyiny, in addition, by modifying the synthesis and catabolism of VLDL fraction fenofibrate increases LDL clearance and reduces the number of low LDL aviary level is elevated in patients at risk of coronary heart aviary (lipid profile atherogenous). / day aviary one of the main meals, diet, started to use the drug, should continue, and if after the drug within 3 months) the level of lipids in the blood serum not declined to consider the appointment of additional treatment or other therapy aviary .